ATE425767T1 - Konjugate von cyanovirin-varianten und einem polyalkylenoxid - Google Patents

Konjugate von cyanovirin-varianten und einem polyalkylenoxid

Info

Publication number
ATE425767T1
ATE425767T1 AT03813787T AT03813787T ATE425767T1 AT E425767 T1 ATE425767 T1 AT E425767T1 AT 03813787 T AT03813787 T AT 03813787T AT 03813787 T AT03813787 T AT 03813787T AT E425767 T1 ATE425767 T1 AT E425767T1
Authority
AT
Austria
Prior art keywords
cyanovirin
conjugates
variants
polyalkylene oxide
water
Prior art date
Application number
AT03813787T
Other languages
English (en)
Inventor
M Snell
Michael Roberts
Toshiyuki Mori
Barry O'keefe
Michael Boyd
Original Assignee
Nektar Therapeutics Al Corp
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics Al Corp, Us Gov Health & Human Serv filed Critical Nektar Therapeutics Al Corp
Application granted granted Critical
Publication of ATE425767T1 publication Critical patent/ATE425767T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyethers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03813787T 2002-12-19 2003-12-18 Konjugate von cyanovirin-varianten und einem polyalkylenoxid ATE425767T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43595002P 2002-12-19 2002-12-19
US46173103P 2003-04-09 2003-04-09

Publications (1)

Publication Number Publication Date
ATE425767T1 true ATE425767T1 (de) 2009-04-15

Family

ID=32685420

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03813787T ATE425767T1 (de) 2002-12-19 2003-12-18 Konjugate von cyanovirin-varianten und einem polyalkylenoxid

Country Status (10)

Country Link
US (2) US7267941B2 (de)
EP (1) EP1620129B1 (de)
JP (2) JP2006517400A (de)
KR (1) KR101145990B1 (de)
AT (1) ATE425767T1 (de)
AU (1) AU2003301122B2 (de)
CA (1) CA2507904C (de)
DE (1) DE60326774D1 (de)
MX (1) MXPA05006688A (de)
WO (1) WO2004056852A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2507904C (en) * 2002-12-19 2014-12-02 M. Elizabeth Snell Cyanovirin variant-polymer conjugates
US7432331B2 (en) 2002-12-31 2008-10-07 Nektar Therapeutics Al, Corporation Hydrolytically stable maleimide-terminated polymers
WO2007037245A1 (ja) * 2005-09-29 2007-04-05 Shionogi & Co., Ltd. 血管新生抑制作用を有するポリペプチド
SI2054074T1 (sl) 2006-08-04 2014-12-31 Prolong Pharmaceuticals Llc Modificiran eritropoetin
ATE531385T1 (de) * 2006-08-18 2011-11-15 Us Gov Health & Human Serv Anti-h5n1-influenza-aktivität des antiviralen proteins cyanovirin
CA2663300C (en) 2006-09-15 2014-10-07 Creabilis Therapeutics S.P.A. Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1
CN101143894A (zh) * 2007-06-22 2008-03-19 中国药科大学 高效抑制血管生成多肽及其物理化学修饰方法和应用
CA2710518C (en) * 2007-12-27 2018-07-17 Baxter International Inc. Method and compositions for specifically detecting physiologically acceptable polymer molecules
MX344076B (es) 2008-06-30 2016-12-05 Esbatech Alcon Biomed Res Unit Polipeptidos funcionalizados.
JP5588983B2 (ja) 2008-08-11 2014-09-10 ウェルズ ファーゴ バンク ナショナル アソシエイション マルチアームポリマーアルカノエートコンジュゲート
PT2349342T (pt) * 2008-10-17 2018-10-26 Baxalta Inc Factores sanguíneos modificados que compreendem um baixo grau de polímero solúvel na água
PL2431741T3 (pl) * 2008-10-21 2014-01-31 Baxalta Inc Sposoby określania ilości aktywnych składników w prolekach, będących koniugatami PEG-białko, za pomocą reagentów uwalniających PEG (depegylacja in vitro)
EP2471915B1 (de) * 2009-08-28 2018-05-23 The Chemo-Sero-Therapeutic Research Institute Aus influenza-m2 gewonnener modifizierter peptidimpfstoff
CN101638435B (zh) * 2009-09-04 2011-11-16 暨南大学 一种蓝藻病毒蛋白n突变体、其修饰衍生物及应用
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
WO2012166555A1 (en) 2011-05-27 2012-12-06 Nektar Therapeutics Water - soluble polymer - linked binding moiety and drug compounds
CN104220097B (zh) * 2011-12-19 2019-08-09 建新公司 促甲状腺激素组合物
WO2019108656A1 (en) 2017-11-28 2019-06-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Microbicidal composition
CN111741770A (zh) * 2017-12-29 2020-10-02 豪夫迈·罗氏有限公司 用于提供聚乙二醇化蛋白质组合物的方法
CN111727063A (zh) * 2017-12-29 2020-09-29 豪夫迈·罗氏有限公司 用于提供聚乙二醇化蛋白质组合物的方法
HRP20220041T1 (hr) 2017-12-29 2022-04-15 F. Hoffmann - La Roche Ag Postupak za dobivanje pegiliranog proteinskog pripravka
CN116854785A (zh) * 2023-05-16 2023-10-10 青岛双元泰和药业有限公司 位点特异性修饰和标记的抗病毒肽氰病毒素n

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766897A (en) 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
US6780847B2 (en) * 1995-04-27 2004-08-24 The United States Of America As Represented By The Department Of Health And Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
KR20110014661A (ko) 2002-02-07 2011-02-11 노보자임스 바이오파마 디케이 에이/에스 알부민-융합 쿠니츠 도메인 펩타이드
CA2507904C (en) * 2002-12-19 2014-12-02 M. Elizabeth Snell Cyanovirin variant-polymer conjugates

Also Published As

Publication number Publication date
KR101145990B1 (ko) 2012-08-23
MXPA05006688A (es) 2006-02-22
KR20050084433A (ko) 2005-08-26
WO2004056852A3 (en) 2004-10-07
WO2004056852A2 (en) 2004-07-08
EP1620129A2 (de) 2006-02-01
JP2011050382A (ja) 2011-03-17
US20080015151A1 (en) 2008-01-17
US7267941B2 (en) 2007-09-11
AU2003301122B2 (en) 2009-11-26
US7547509B2 (en) 2009-06-16
CA2507904C (en) 2014-12-02
CA2507904A1 (en) 2004-07-08
DE60326774D1 (de) 2009-04-30
AU2003301122A1 (en) 2004-07-14
JP4903891B2 (ja) 2012-03-28
US20040258706A1 (en) 2004-12-23
JP2006517400A (ja) 2006-07-27
EP1620129B1 (de) 2009-03-18

Similar Documents

Publication Publication Date Title
ATE425767T1 (de) Konjugate von cyanovirin-varianten und einem polyalkylenoxid
TW200631604A (en) Ophthalmic compositions comprising polyether substituted polymers
DE602004019546D1 (de) Heterofunktionelle copolymere von glycerol und polyethylenglykol, ihre konjugate und zusammensetzungen
DE50010132D1 (de) Wasserlösliche oder wasserquellbare Polymerisate
MX2007005724A (es) Articulo para tratamiento cosmetico que comprende un sustrato y una composicion en gel.
DE502004010014D1 (de) Anionische ampholytische copolymere
CY1117349T1 (el) Πολυμερικες ενωσεις πολυαλκυλενιου και χρησεις αυτων
BR0207378A (pt) Tratamento de câncer
NO20021862D0 (no) Katalysatorsammensetninger, fremgangsmåter for polymerisasjon og polymerer derfra
DE60208177D1 (de) Propylenpolymerzusammensetzung, formkörper und polyolefincopolymer
BR0210335A (pt) Copolìmero de blocos, e, composição
TW200510454A (en) Conjugates comprising human IL-18 and substitution mutants thereof
DK2287204T3 (da) Vandopløslige jern-kulhydrat-komplekser, fremstilling deraf og læge-midler, der indeholder disse
FR2811996B1 (fr) Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
MXPA03011935A (es) Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco.
DE60219677D1 (de) Wasserlösliche polymerkonjugate von retinoesäure
IT1318488B1 (it) Fluorovinileteri e polimeri da essi ottenibili.
FR2819516B1 (fr) Polymere comprenant des unites hydrosolubles et des unites a lcst et composition aqueuse le comprenant
DE69927688D1 (de) Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs
WO2003106384A3 (en) Novel boronic chalcone derivatives and uses thereof
DK1379508T3 (da) N-(aryl)-2arylethensulfonamider og terapeutiske anvendelser deraf
CY1105020T1 (el) Υποκαταστατες διαζεπανες
ATE443453T1 (de) Tomatenprodukte
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
AU2003233579A8 (en) Synthesis of inorganic structures using templation and catalysis by self assembled repeat protein polymers

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties